AstraZeneca is beating the odds this week. The COVID-19 vaccination is still controversial, but it doesn’t stop the company’s stock price rising. With the 1.3% increase today, the share price has recently surged over 8% within only five days, building on the enthusiasm from the strong Q1 results announced last …
Read More »